Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer
Clinical trial NCT04792515 · UNKNOWN
Trial details
- NCT number
- NCT04792515
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-06-30
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.